BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9333703)

  • 1. [Stage-oriented antibiotic therapy of peritonitis. Prospective study].
    Winkeltau GJ; Töns C; Bertram P; Schumpelick V
    Langenbecks Arch Chir; 1997; 382(4 Suppl 1):S22-5. PubMed ID: 9333703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiated surgical therapy of diffuse peritonitis--a prospective study].
    Winkeltau GJ; Bertram P; Braun J; Schumpelick V
    Leber Magen Darm; 1996 May; 26(3):144-8. PubMed ID: 8709828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime and metronidazole in severe intra-abdominal infection.
    Aprahamian C; Schein M; Wittmann D
    Diagn Microbiol Infect Dis; 1995; 22(1-2):183-8. PubMed ID: 7587037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
    Navasa M; Follo A; Llovet JM; Clemente G; Vargas V; Rimola A; Marco F; Guarner C; Forné M; Planas R; Bañares R; Castells L; Jimenez De Anta MT; Arroyo V; Rodés J
    Gastroenterology; 1996 Oct; 111(4):1011-7. PubMed ID: 8831596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of metronidazole lavage in treatment of intraperitoneal sepsis. A prospective study.
    Saha SK
    Dig Dis Sci; 1996 Jul; 41(7):1313-8. PubMed ID: 8689905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation].
    Staubach KH
    Langenbecks Arch Chir; 1997; 382(4 Suppl 1):S26-30. PubMed ID: 9333704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.
    Taşkiran B; Colakoğlu O; Sözmen B; Unsal B; Aslan SL; Buyraç Z
    Turk J Gastroenterol; 2004 Mar; 15(1):34-8. PubMed ID: 15264119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical management of severe peritonitis].
    Giessling U; Petersen S; Freitag M; Kleine-Kraneburg H; Ludwig K
    Zentralbl Chir; 2002 Jul; 127(7):594-7. PubMed ID: 12122587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotaxime in the treatment of spontaneous bacterial peritonitis.
    Xiol X; Ariza J
    Hepatology; 1996 Apr; 23(4):941-2. PubMed ID: 8666356
    [No Abstract]   [Full Text] [Related]  

  • 10. [Surgical therapy of peritonitis].
    Strobel O; Werner J; Büchler MW
    Chirurg; 2011 Mar; 82(3):242-8. PubMed ID: 21416396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of single dose cefotaxime plus metronidazole compared with three doses each of cefuroxime plus metronidazole for the prevention of wound infection after colorectal surgery.
    Davey P; Lynch B; Malek M; Byrne D; Thomas P
    J Antimicrob Chemother; 1992 Dec; 30(6):855-64. PubMed ID: 1289360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone/metronidazole is more effective than ampicillin/netilmicin/metronidazole in the treatment of bacterial peritonitis.
    Luke M; Iversen J; Søndergaard J; Kvist E; Lund P; Andersen F; Naver L; Larsen PN; Clausen B; Prag J
    Eur J Surg; 1991; 157(6-7):397-401. PubMed ID: 1681917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics.
    Nix DE; Schentag JJ
    Diagn Microbiol Infect Dis; 1995; 22(1-2):71-6. PubMed ID: 7587053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical therapy of abdominal infection--reliable strategies].
    Teichmann W; Mansfeld T
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():732-7. PubMed ID: 11824355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study.
    Rowe-Jones DC; Peel AL; Kingston RD; Shaw JF; Teasdale C; Cole DS
    BMJ; 1990 Jan; 300(6716):18-22. PubMed ID: 2105115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of diagnostics and therapy of complicated intraabdominal infections].
    Knaebel HP; Seiler CM; Weigand MA; Büchler MW
    Zentralbl Chir; 2007 Oct; 132(5):419-26. PubMed ID: 17907084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of peritonitis today. Surgical management and adjuvant therapy strategies].
    Reith HB
    Langenbecks Arch Chir; 1997; 382(4 Suppl 1):S14-7. PubMed ID: 9333701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
    Schuler D
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():99-108. PubMed ID: 8543503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic treatment of intra-abdominal and post-surgical infections].
    Sganga G
    Infez Med; 2005; Suppl():18-24. PubMed ID: 16801749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic scores in peritonitis: the Mannheim Peritonitis Index or APACHE II?].
    Demmel N; Muth G; Maag K; Osterholzer G
    Langenbecks Arch Chir; 1994; 379(6):347-52. PubMed ID: 7845160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.